US20080051603A1 - Process for the preparation of poly-alpha-glutamic acid and derivatives thereof - Google Patents

Process for the preparation of poly-alpha-glutamic acid and derivatives thereof Download PDF

Info

Publication number
US20080051603A1
US20080051603A1 US11/818,056 US81805607A US2008051603A1 US 20080051603 A1 US20080051603 A1 US 20080051603A1 US 81805607 A US81805607 A US 81805607A US 2008051603 A1 US2008051603 A1 US 2008051603A1
Authority
US
United States
Prior art keywords
acid
process according
glutamic acid
poly
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/818,056
Inventor
Marc McKennon
Giovanni Da Re
Luca Feliciotti
Marco Artico
Gianluca Pardi
Mario Grugni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Therapeutics Inc
Original Assignee
Cell Therapeutics Europe SRL
Cell Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06012351A external-priority patent/EP1867657A1/en
Application filed by Cell Therapeutics Europe SRL, Cell Therapeutics Inc filed Critical Cell Therapeutics Europe SRL
Priority to US11/818,056 priority Critical patent/US20080051603A1/en
Assigned to CELL THERAPEUTICS EUROPE S.R.L. reassignment CELL THERAPEUTICS EUROPE S.R.L. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ARTICO, MARCO, DA RE, GIOVANNI, FELICIOTTI, LUCA, GRUGNI, MARIO, PARDI, GIANLUCA
Assigned to CELL THERAPEUTICS, INC. reassignment CELL THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCKENNON, MARC
Assigned to CELL THERAPEUTICS, INC. reassignment CELL THERAPEUTICS, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: CELL THERAPEUTICS EUROPE S.R.L.
Publication of US20080051603A1 publication Critical patent/US20080051603A1/en
Priority to US12/965,510 priority patent/US8329853B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids

Definitions

  • the present invention relates to a process for the preparation of poly- ⁇ -glutamic acid and derivatives thereof, and compounds therefrom.
  • Poly- ⁇ -glutamic acid of formula (I) is currently used as drug delivery system, for example for the preparation of conjugates with a wide variety of drugs containing a primary or secondary amino group as well as primary, secondary or tertiary hydroxy groups.
  • the conjugation can occur directly or through a suitable linker, for example an amino acid or a hydroxyacid. See, for example, EP0932399, Advanced Drug Delivery Reviews, Volume 54, Issue 5, 2002, Pages 695-713 and Journal of Controlled Release, Volume 74, Issues 1-3, 2001, Pages 243-247.
  • Poly- ⁇ -glutamic acid can be synthesized by polymerization of suitably protected glutamic acid.
  • U.S. Pat. No. 3,635,909 discloses, inter alia, the polymerization of D-glutamic acid- ⁇ -(tert-butyl)ester N-carboxy anhydride in a 1,2-dichloroethane/1,4-dioxane mixture using sodium 4-methyl-2-pyrrolidone as initiator.
  • the present invention provides a process for the preparation of poly- ⁇ -glutamic acid of formula (I) wherein the symbol * indicates a chiral center and n is between 60 and 310, so that the poly- ⁇ -glutamic acid has a molecular weight ranging from 8,000 to 40,000 Da
  • the present invention provides a process for the preparation of a poly- ⁇ -glutamic acid derivative of formula (IV) wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310 and R 1 CO— is selected from:
  • step b) reaction of a compound of formula (III) obtained according to step a) above with a carboxylic acid R 1 COOH, or an acyl chloride R 1 COCl or an anhydride (R 1 CO) 2 O wherein R 1 is as defined above, in the presence of a dehydrating agent to give a compound of formula (V) and
  • the present invention provides a poly- ⁇ -glutamic acid derivative of formula (IV) wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310 and R 1 CO— is selected from:
  • D- or L-amino acid and non-natural amino acid residues as well as their salts with inorganic acids or bases.
  • the present invention provides a poly- ⁇ -glutamic acid derivative of formula (V) wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310, R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl, R′ is hydrogen or a t-butyl or methyl group and R 1 CO is selected from:
  • the invention relates to a process for the preparation of poly- ⁇ -glutamic acid of formula (I) wherein n is an integer comprised between 60 and 310, so that the poly- ⁇ -glutamic acid has a molecular weight ranging from 8,000 to 40,000 Da, preferably from 10,000 to 35,000 Da, more preferably from 13,000 to 16,000 Da, and with a polydispersity index usually ⁇ 2, preferably ⁇ 1.5,
  • glutamic acid comprises both the L- and D-form, either as pure isomers or as racemic mixture.
  • Step a) is usually carried out at a temperature ranging from 10 to 50° C., with a concentration of the ⁇ -ester of ⁇ -glutamic acid N-carboxy anhydride ranging from 0.1 to 0.3 M.
  • the process is carried out using 1,4-dioxane as the solvent and DBU as the initiator.
  • the molar ratio of ⁇ -ester of ⁇ -glutamic acid N-carboxy anhydride to initiator usually ranges from 2 to 25; the molar ratio of 7-ester of ⁇ -glutamic acid N-carboxy anhydride to ⁇ -glutamic acid ⁇ -ester is 100.
  • Step b) can be carried out using any reagent conventionally used for the removal of tert-butyl esters, as exemplified by those described in “Protective groups in organic synthesis” Third edition, Theodora W. Greene and Peter G. M. Wuts, a Wiley-Interscience publication—John Wiley & Sons, Inc, page 406-408 and references therein.
  • Preferred conditions include trifluoroacetic acid (TFA), formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.; TFA is used in amount of 100 v/w, while formic acid and water/formic acid mixtures are used in amounts ranging from 20 to 50 v/w.
  • TFA trifluoroacetic acid
  • the process of the invention is suitable for preparing both the D and L form of poly- ⁇ -glutamic acids, in particular the L form.
  • the poly- ⁇ -glutamic acids prepared according to the invention can be easily converted into their acidic or basic salts by reaction with inorganic acids, such as hydrochloric acid, hydrobromic acid, sulphuric acid, nitric acid, perchloric acid or with inorganic bases such as alkaline or alkaline-earth metal hydroxides and ammonium hydroxide.
  • the process of the invention provides poly- ⁇ -glutamic acid with a weight average molecular weight (M w ) determined by Gel Permeation Chromatography combined with Multi Angle Laser Light Scattering detection, ranging within the values defined above, preferably between 13,000 and 16,000 Da and with a polydispersity index ⁇ 1.5.
  • M w weight average molecular weight
  • This is particularly advantageous, since the procedures disclosed in the literature, through different ⁇ -protecting groups (such as benzyl, methyl or ethyl; see Polymer monographs, Volume 9: H. Block, Poly( ⁇ -benzyl-L-glutamate) and other glutamic acid containing polymers. Edited by B. Huglin, University of Salford), afford materials of uncontrolled and very high molecular weight, which often require chromatographic separation to isolate poly- ⁇ -glutamic acids having a desired molecular weight range.
  • the process of the invention allows avoidance of spontaneous formation of a pyroglutamic ester at the amino terminus, which usually occurs during polymerization using, for example, ⁇ -benzyl, ⁇ -methyl or ⁇ -ethyl glutamic acid ester N-carboxy anhydride.
  • poly- ⁇ -glutamic acids exhibit either a pyroglutamic terminus, or an amino terminus or a mixture thereof. Suppression of formation of a pyroglutamic terminus is achieved in particular when a compound of formula (II) wherein R is a t-butyl group is used as the starting material.
  • Poly- ⁇ -glutamic acids ⁇ -esters with a free amino terminus can thus be reacted either with stoichiometric amounts of pyroglutamic acid or with other suitable acids, so as to achieve 100% conversion into the desired N-capped poly- ⁇ -glutamic acid.
  • the present invention provides also a process for the preparation of poly- ⁇ -glutamic acid derivatives of formula (IV) wherein n is as defined above and R 1 CO— is selected from:
  • step a) comprising reacting a compound of formula (III) obtained according to step a) above with a carboxylic acid R 1 COOH in the presence of a dehydrating agent, or with an activated carboxylic acid, such as an acyl chloride R 1 COCl or an anhydride (R 1 CO) 2 O, wherein R 1 CO— is as defined above, to give a compound of formula (V) and hydrolyzing the compound of formula (V) to a compound of formula (IV).
  • a carboxylic acid R 1 COOH in the presence of a dehydrating agent, or with an activated carboxylic acid, such as an acyl chloride R 1 COCl or an anhydride (R 1 CO) 2 O, wherein R 1 CO— is as defined above
  • (C 1 -C 10 )alkylcarbonyl examples are acetyl and butyryl;
  • (C 4 -C 8 )cycloalkylcarbonyl examples are cyclopropylcarbonyl, cyclobutanecarbonyl, cyclohexylcarbonyl;
  • (C 2 -C 6 )carboxyalkylcarbonyl is succinyl
  • Examples of (C 6 -C 10 )aryl carbonyl are benzoyl, 1-naphthoyl, 2-naphthoyl;
  • (C 6 -C 10 )aryl(C 1 -C 10 )alkylcarbonyl examples are phenylacetyl and phenylbutyryl;
  • (C 1 -C 10 )alkyl(C 6 -C 10 )arylcarbonyl examples are o-, m- and p-tolyl;
  • Examples of (C 5 -C 10 )heteroarylcarbonyl are nicotinoyl, N-methylpyrrole-3-carbonyl, 3-thiophenecarbonyl and 3-quinolinecarbonyl;
  • (C 5 -C 10 )heteroaryl(C 1 -C 10 )alkylcarbonyl is 3-pyridyl acetyl
  • D- or L-natural amino acid residues are those deriving from glycine, alanine, valine, leucine, isoleucine, serine, threonine, lysine, pyroglutamic acid, phenylalanine, tryptophan, cysteine;
  • non-natural amino acid residues are those deriving from ⁇ -alanine, ⁇ , ⁇ -dimethylglycine, ⁇ -phenylglycine, homophenylalanine, 3-amino-3-(4-methylphenyl)propionic acid, and 2-(1-aminocyclopentyl)acetic acid.
  • a dehydrating agent commonly used in peptide chemistry like carbodiimides, such as dicyclohexylcarbodiimide and diisopropylcarbodiimide, uronium salts, such as 2-1H-7-azabenzotriazol-1-yl-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (HATU), 2-(1H-benzotriazol-1-yl)-1,1,3,3-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (HBTU) and 2-(1H-6-chlorobenzotriazol-1-yl)-1,1,3,3-N,N, N′,N′-tetramethyluronium-hexafluorophosphate (HCTU), phosphonium salts, such as benzotriazol-1-yloxytris(
  • a natural or non-natural amino acid When a natural or non-natural amino acid is used as the capping agent, its amino group is preferably protected by a suitable protecting group, preferably the t-butoxycarbonyl protecting group. Subsequent acidic hydrolysis of the N-capped poly- ⁇ -glutamic acid- ⁇ -ester as described in step b) above then provides the N-capped poly- ⁇ -glutamic acid.
  • the compounds of formula (IV) can be converted into their acidic or basic salts by reaction with inorganic acids, such as hydrochloric acid, hydrobromic acid, sulphuric acid, nitric acid, perchloric acid or with inorganic bases such as alkaline or alkaline-earth metal hydroxides and ammonium hydroxide.
  • a particularly preferred embodiment is a compound of formula (IV) wherein R 1 CO is a D- or L-pyroglutamic acid residue and the content of the N-terminus free amine is lower than 1% w/w, preferably lower than 0.2% w/w.
  • any compound able to react with the —NH 2 terminus can be used for the reaction with the compound of formula (III).
  • Examples of such compounds are aldehydes, ketones, ⁇ , ⁇ -unsaturated ketones, sulfonyl chlorides and nitriles, which can be reacted with compound (III) according to methods known to the skilled chemist.
  • either the carboxylic acid, or activated carboxylic acid, or anhydride, or compound able to react with the —NH 2 terminus may also bear at least a group, such as a hydroxy, an amino or a thio group, which can be further functionalized with a moiety suitable for modulating the pharmacokinetic properties of poly- ⁇ -glutamic acid. Therefore, another aspect of the present invention is also a poly- ⁇ -glutamic acid substituted at the —NH 2 terminus with a group which is able to be further functionalized with a moiety suitable for modulating the pharmacokinetic properties of poly- ⁇ -glutamic acid.
  • the resulting pure white solid was filtered on a buchner funnel and washed with 3 ⁇ 90 mL of n-heptane, then dried in the oven under dynamic vacuum at 20/25° C. for no longer than 20 hours.
  • the solid must be used as soon as possible and must be stored under static vacuum in the presence of silica gel.
  • N-carboxy anhydride N-carboxy anhydride
  • 1,8-Diazabiciclo[5.4.0]undec-7-ene free base (DBU; MW 152.24; 585 mg, 3.84 mmol) was dissolved in 1,4-dioxane (5 mL from the total amount) in few minutes.
  • Solid poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester (4 g) was suspended in formic acid 99% (80 mL, 20 volumes) under nitrogen atmosphere in a 100 mL jacketed glass reactor. The mixture was stirred at 60° C. for 5 hours. After about a 30-minute heating the suspension turned into solution, then a solid began to precipitate.
  • the resulting residue was suspended in water (40 mL) and the mixture was cooled to 3-5° C., then 30% w/w NaOH was carefully added to reach pH 8. Once the pH was stable at 23-25° C., the resulting solution was filtered through a 0.22 ⁇ m microfilter.
  • reaction mixture was concentrated to dryness and the residue was rinsed with fresh 1,4-dioxane (100 mL). Two volumes of water were then added to the reaction mixture which was stirred for 30 minutes. The precipitated solid was collected, washed with water and dried under vacuum at 40° C. for at least 12 hours.
  • a typical poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester obtained according to an experimental procedure herein described (see Example 1 and 2), contains about 1% moles of free amino groups at the N-terminus, as determined by 1 H-NMR analysis. This percentage was used to calculate the molar equivalents of the suitable acid to add to poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester for its capping reaction.
  • Poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester was dissolved in THF (20 mL/g) then a catalytic amount of 4-dimethylaminopyridine (DMAP; about 5-10% moles with respect to the added acid) was added.
  • DMAP 4-dimethylaminopyridine
  • the suitable acid (10 molar equivalents) was added to the previous mixture and diisopropylcarbodiimide (DIPC, 50% molar excess with respect to the acid added) was dropwise added in about 10 min. The solution was stirred for 2 hours.
  • the precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-terminus phenylalanine-capped poly- ⁇ -L-glutamic acid, i.e., N-phenylalanyl-poly- ⁇ -L-glutamic acid (530 mg, 84% recovery).
  • the 1 H-NMR was consistent with the proposed structure.
  • N-terminal free amine content (clearly detectable at the poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester stage) was no longer detectable by 1 H-NMR analysis or by analysis following derivatization with o-phthalaldehyde.
  • the 1 H-NMR was consistent with the proposed structure and the free amine (clearly detectable at the poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester stage) was no longer detectable by 1 H-NMR or o-phthalaldehyde analysis.
  • the resulting mixture was stirred for 2 h at 60° C.
  • the solid residue was dissolved in aqueous NaHCO 3 and the resulting solution was ultrafiltered through a 5000 Da cutoff membrane.
  • the retentate was concentrated to about 30 mL and acidified by means of sulfuric acid until pH 2-2.5.
  • the precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-(Naphthalen-2-yl-acetyl)-poly- ⁇ -L-glutamic acid (570 mg, 82% recovery).
  • the 1 H-NMR was consistent with the proposed structure and the free amine (clearly detectable at the poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester stage) was no longer detectable by 1 H-NMR or o-phthalaldehyde analysis.
  • Poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester (n ⁇ 100; 1 g, 0.054 mmol) was dissolved in THF (20 mL) and catalytic DMAP (8 mg, 0.07 mmol) was added. Then 2-thiophenebutyric acid (119 mg, 0.7 mmol) was added to the mixture and immediately after DIPC (160 ⁇ L, 1 mmol) was dropwise added. The resulting solution was stirred for about two hours then water (2 volumes) was added and a white precipitate formed immediately. The suspension was stirred for 30 min and filtered, then the white powdered solid was suspended in formic acid (18 mL). The resulting mixture was stirred for 2 h at 60° C.
  • the precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-terminus 2-thiophenebutyroyl-capped poly- ⁇ -L-glutamic acid, i.e., N-(2-thiophenebutyroyl)-poly- ⁇ -L-glutamic acid (480 mg, 76% recovery).
  • the 1 H-NMR was consistent with the proposed structure.
  • N-terminal free amine content (clearly detectable at the poly- ⁇ -L-glutamic acid- ⁇ -(tert-butyl)ester stage) was no longer detectable by 1 H-NMR analysis or by analysis following derivatisation with o-phthalaldehyde.
  • N-(2-thiophenepropanoyl)-poly- ⁇ -L-glutamic acid and N-(2-thiophenepentanoyl)-poly- ⁇ -L-glutamic acid were also obtained.

Abstract

The invention relates to an improved process for the preparation of poly-α-glutamic acids which comprises the polymerization of tertiary γ-esters of α-glutamic acid N-carboxy anhydride with appropriate solvents and initiators, followed by acid hydrolysis of the resulting poly-α-glutamic acid-γ-ester. The process is particularly advantageous in that it allows one to carefully control the molecular weight of the resulting poly-α-glutamic acid. The invention also relates to poly-α-glutamic acids capped at the amino terminus with carboxylic acids or amino acids and to a process for the preparation thereof.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 60/813,787 filed Jun. 15, 2006 and priority to European Patent Application No. 06012351.0 filed Jun. 15, 2006; which applications are incorporated by reference herein in their entirety.
  • BACKGROUND
  • 1. Technical Field
  • The present invention relates to a process for the preparation of poly-α-glutamic acid and derivatives thereof, and compounds therefrom.
  • 2. Description of the Related Art
  • Poly-α-glutamic acid of formula (I)
    Figure US20080051603A1-20080228-C00001

    is currently used as drug delivery system, for example for the preparation of conjugates with a wide variety of drugs containing a primary or secondary amino group as well as primary, secondary or tertiary hydroxy groups. The conjugation can occur directly or through a suitable linker, for example an amino acid or a hydroxyacid. See, for example, EP0932399, Advanced Drug Delivery Reviews, Volume 54, Issue 5, 2002, Pages 695-713 and Journal of Controlled Release, Volume 74, Issues 1-3, 2001, Pages 243-247.
  • Poly-α-glutamic acid can be synthesized by polymerization of suitably protected glutamic acid. U.S. Pat. No. 3,635,909 discloses, inter alia, the polymerization of D-glutamic acid-γ-(tert-butyl)ester N-carboxy anhydride in a 1,2-dichloroethane/1,4-dioxane mixture using sodium 4-methyl-2-pyrrolidone as initiator.
  • BRIEF SUMMARY
  • Briefly stated, compounds and processes for the preparation of poly-α-glutamic acid and derivatives thereof are provided.
  • In an embodiment, the present invention provides a process for the preparation of poly-α-glutamic acid of formula (I)
    Figure US20080051603A1-20080228-C00002

    wherein the symbol * indicates a chiral center and n is between 60 and 310, so that the poly-α-glutamic acid has a molecular weight ranging from 8,000 to 40,000 Da
  • the process comprising the steps of:
  • a) polymerization of a tertiary γ-ester of α-glutamic acid N-carboxy anhydride of formula (II)
    Figure US20080051603A1-20080228-C00003

    wherein the symbol * is as defined above and R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl
  • in water or in an organic solvent selected from: tetrahydrofuran, 1,4-dioxane, dimethylformamide, 1,4-dioxane/DMF and 1,4-dioxane/tetrahydrofuran mixture with an initiator selected from potassium tert-butoxide, sodium methoxide, diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene, dimethylaminopyridine and L-glutamic acid-γ-tert-butylester, to give a compound of formula (III)
    Figure US20080051603A1-20080228-C00004

    wherein * and R are as defined above and R′ is hydrogen when the initiator is selected from diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene, 4-dimethylaminopyridine, glutamic acid dimethyl ester and glutamic acid-γ-tert-butyl ester or R′ is a t-butyl or methyl group when the initiator is potassium tert-butoxide and sodium methoxide respectively; and followed by
  • b) acid hydrolysis of the γ- and α-ester groups to give a compound of formula (I).
  • In an embodiment, the present invention provides a process for the preparation of a poly-α-glutamic acid derivative of formula (IV)
    Figure US20080051603A1-20080228-C00005

    wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310 and R1CO— is selected from:
  • (C1-C10)alkylcarbonyl;
  • (C4-C8)cycloalkylcarbonyl;
  • (C2-C6)carboxyalkylcarbonyl;
  • (C6-C10)arylcarbonyl;
  • (C6-C10)aryl(C1-C10)alkylcarbonyl;
  • (C1-C10)alkyl(C6-C10)arylcarbonyl;
  • (C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; and
  • D- or L-amino acid and non-natural amino acid residues; the process comprising the steps of:
  • a) polymerization of a tertiary γ-ester of an α-glutamic acid N-carboxy anhydride of formula (II)
    Figure US20080051603A1-20080228-C00006

    wherein * is as defined above and R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl
  • in water or in an organic solvent selected from: tetrahydrofuran, 1,4-dioxane, dimethylformamide, 1,4-dioxane/DMF and 1,4-dioxane/tetrahydrofuran mixtures with an initiator selected from potassium tert-butoxide, sodium methoxide, diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene, dimethylaminopyridine and L-glutamic acid-γ-tert-butylester, to give a compound of formula (III);
  • b) reaction of a compound of formula (III)
    Figure US20080051603A1-20080228-C00007

    obtained according to step a) above with a carboxylic acid R1COOH, or an acyl chloride R1COCl or an anhydride (R1CO)2O wherein R1 is as defined above, in the presence of a dehydrating agent to give a compound of formula (V)
    Figure US20080051603A1-20080228-C00008

    and
  • c) the hydrolysis of the compound of formula (V) to give a compound of formula (IV).
  • In an embodiment, the present invention provides a poly-α-glutamic acid derivative of formula (IV)
    Figure US20080051603A1-20080228-C00009

    wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310 and R1CO— is selected from:
  • (C1-C10)alkylcarbonyl;
  • (C4-C8)cycloalkylcarbonyl;
  • (C6-C10)arylcarbonyl;
  • (C6-C10)aryl(C1-C10)alkylcarbonyl;
  • (C1-C10)alkyl(C6-C10)arylcarbonyl;
  • (C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; and
  • D- or L-amino acid and non-natural amino acid residues as well as their salts with inorganic acids or bases.
  • In an embodiment, the present invention provides a poly-α-glutamic acid derivative of formula (V)
    Figure US20080051603A1-20080228-C00010

    wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310, R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl, R′ is hydrogen or a t-butyl or methyl group and R1CO is selected from:
  • (C1-C10)alkylcarbonyl;
  • (C4-C8)cycloalkylcarbonyl;
  • (C6-C10)arylcarbonyl;
  • (C6-C10)aryl(C1-C10)alkylcarbonyl;
  • (C1-C10)alkyl(C6-C10)arylcarbonyl;
  • (C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; and
  • D- or L-amino acid and non-natural amino acid residues.
  • These and other aspects of the present invention will become apparent upon reference to the following detailed description.
  • DETAILED DESCRIPTION
  • The present disclosure shows that appropriate choice of the solvent and of the initiator allows the control of the molecular weight of poly-α-glutamic acid prepared from tertiary γ-esters of α-glutamic acid N-carboxy anhydride. Accordingly, in one aspect the invention relates to a process for the preparation of poly-α-glutamic acid of formula (I)
    Figure US20080051603A1-20080228-C00011

    wherein n is an integer comprised between 60 and 310, so that the poly-α-glutamic acid has a molecular weight ranging from 8,000 to 40,000 Da, preferably from 10,000 to 35,000 Da, more preferably from 13,000 to 16,000 Da, and with a polydispersity index usually ≦2, preferably ≦1.5,
  • said process comprising the steps of:
  • a. polymerization of a tertiary γ-ester of α-glutamic acid N-carboxy anhydride of formula (II)
    Figure US20080051603A1-20080228-C00012

    wherein R is selected from t-butyl, 1,1-dimethylpropyl- and 1,1-dimethylbutyl- and is preferably a t-butyl group either in water or in an organic solvent selected from tetrahydrofuran (THF), 1,4-dioxane, dimethylformamide (DMF), 1,4-dioxane/DMF and 1,4-dioxane/tetrahydrofuran mixtures with an initiator selected from potassium tert-butoxide (t-BuOK), sodium methoxide (MeONa), diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), 4-dimethylaminopyridine (DMAP), glutamic acid dimethyl ester, and glutamic acid-γ-tert-butyl ester, to give a compound of formula (III)
    Figure US20080051603A1-20080228-C00013

    wherein n and R are as defined above and R′ is hydrogen when the initiator is selected from diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), 4-dimethylaminopyridine (DMAP), glutamic acid dimethyl ester and glutamic acid-γ-tert-butyl ester or R′ is a t-butyl or methyl group when the initiator is t-BuOK and MeONa respectively; and followed by
  • b. acid hydrolysis of the γ- and α-ester groups to give a compound of formula (I).
  • Throughout the specification, the symbol * indicates a chiral center and the term glutamic acid comprises both the L- and D-form, either as pure isomers or as racemic mixture.
  • Step a) is usually carried out at a temperature ranging from 10 to 50° C., with a concentration of the γ-ester of α-glutamic acid N-carboxy anhydride ranging from 0.1 to 0.3 M. According to a preferred embodiment, the process is carried out using 1,4-dioxane as the solvent and DBU as the initiator.
  • The molar ratio of γ-ester of α-glutamic acid N-carboxy anhydride to initiator usually ranges from 2 to 25; the molar ratio of 7-ester of α-glutamic acid N-carboxy anhydride to α-glutamic acid γ-ester is 100.
  • Step b) can be carried out using any reagent conventionally used for the removal of tert-butyl esters, as exemplified by those described in “Protective groups in organic synthesis” Third edition, Theodora W. Greene and Peter G. M. Wuts, a Wiley-Interscience publication—John Wiley & Sons, Inc, page 406-408 and references therein. Preferred conditions include trifluoroacetic acid (TFA), formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.; TFA is used in amount of 100 v/w, while formic acid and water/formic acid mixtures are used in amounts ranging from 20 to 50 v/w.
  • The process of the invention is suitable for preparing both the D and L form of poly-α-glutamic acids, in particular the L form. Moreover, the poly-α-glutamic acids prepared according to the invention can be easily converted into their acidic or basic salts by reaction with inorganic acids, such as hydrochloric acid, hydrobromic acid, sulphuric acid, nitric acid, perchloric acid or with inorganic bases such as alkaline or alkaline-earth metal hydroxides and ammonium hydroxide.
  • The process of the invention provides poly-α-glutamic acid with a weight average molecular weight (Mw) determined by Gel Permeation Chromatography combined with Multi Angle Laser Light Scattering detection, ranging within the values defined above, preferably between 13,000 and 16,000 Da and with a polydispersity index ≦1.5. This is particularly advantageous, since the procedures disclosed in the literature, through different γ-protecting groups (such as benzyl, methyl or ethyl; see Polymer monographs, Volume 9: H. Block, Poly(γ-benzyl-L-glutamate) and other glutamic acid containing polymers. Edited by B. Huglin, University of Salford), afford materials of uncontrolled and very high molecular weight, which often require chromatographic separation to isolate poly-α-glutamic acids having a desired molecular weight range.
  • Moreover, the process of the invention allows avoidance of spontaneous formation of a pyroglutamic ester at the amino terminus, which usually occurs during polymerization using, for example, γ-benzyl, γ-methyl or γ-ethyl glutamic acid ester N-carboxy anhydride. In fact, currently available poly-α-glutamic acids exhibit either a pyroglutamic terminus, or an amino terminus or a mixture thereof. Suppression of formation of a pyroglutamic terminus is achieved in particular when a compound of formula (II) wherein R is a t-butyl group is used as the starting material. Poly-α-glutamic acids γ-esters with a free amino terminus can thus be reacted either with stoichiometric amounts of pyroglutamic acid or with other suitable acids, so as to achieve 100% conversion into the desired N-capped poly-α-glutamic acid.
  • Accordingly, in another aspect the present invention provides also a process for the preparation of poly-α-glutamic acid derivatives of formula (IV)
    Figure US20080051603A1-20080228-C00014

    wherein n is as defined above and R1CO— is selected from:
  • (C1-C10)alkylcarbonyl; (C4-C8)cycloalkylcarbonyl; (C2-C6)carboxyalkylcarbonyl; (C6-C10)arylcarbonyl; (C6-C10)aryl(C1-C10)alkylcarbonyl; (C1-C10)alkyl(C6-C10)arylcarbonyl; (C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; D- or L-natural and non-natural amino acid residues
  • said process comprising reacting a compound of formula (III)
    Figure US20080051603A1-20080228-C00015

    obtained according to step a) above with a carboxylic acid R1COOH in the presence of a dehydrating agent, or with an activated carboxylic acid, such as an acyl chloride R1COCl or an anhydride (R1CO)2O, wherein R1CO— is as defined above, to give a compound of formula (V)
    Figure US20080051603A1-20080228-C00016

    and hydrolyzing the compound of formula (V) to a compound of formula (IV).
  • In the compounds of formula (IV) and (V):
  • examples of (C1-C10)alkylcarbonyl are acetyl and butyryl;
  • examples of (C4-C8)cycloalkylcarbonyl are cyclopropylcarbonyl, cyclobutanecarbonyl, cyclohexylcarbonyl;
  • example of (C2-C6)carboxyalkylcarbonyl is succinyl;
  • examples of (C6-C10)aryl carbonyl are benzoyl, 1-naphthoyl, 2-naphthoyl;
  • examples of (C6-C10)aryl(C1-C10)alkylcarbonyl are phenylacetyl and phenylbutyryl;
  • examples of (C1-C10)alkyl(C6-C10)arylcarbonyl are o-, m- and p-tolyl;
  • examples of (C5-C10)heteroarylcarbonyl are nicotinoyl, N-methylpyrrole-3-carbonyl, 3-thiophenecarbonyl and 3-quinolinecarbonyl;
  • example of (C5-C10)heteroaryl(C1-C10)alkylcarbonyl is 3-pyridyl acetyl;
  • examples of D- or L-natural amino acid residues are those deriving from glycine, alanine, valine, leucine, isoleucine, serine, threonine, lysine, pyroglutamic acid, phenylalanine, tryptophan, cysteine;
  • examples of non-natural amino acid residues are those deriving from β-alanine, α,α-dimethylglycine, α-phenylglycine, homophenylalanine, 3-amino-3-(4-methylphenyl)propionic acid, and 2-(1-aminocyclopentyl)acetic acid.
  • The reaction between compound (III) and the acid R1COOH is carried out in the presence of a dehydrating agent commonly used in peptide chemistry, like carbodiimides, such as dicyclohexylcarbodiimide and diisopropylcarbodiimide, uronium salts, such as 2-1H-7-azabenzotriazol-1-yl-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (HATU), 2-(1H-benzotriazol-1-yl)-1,1,3,3-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (HBTU) and 2-(1H-6-chlorobenzotriazol-1-yl)-1,1,3,3-N,N, N′,N′-tetramethyluronium-hexafluorophosphate (HCTU), phosphonium salts, such as benzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP), and the like. When a natural or non-natural amino acid is used as the capping agent, its amino group is preferably protected by a suitable protecting group, preferably the t-butoxycarbonyl protecting group. Subsequent acidic hydrolysis of the N-capped poly-α-glutamic acid-γ-ester as described in step b) above then provides the N-capped poly-α-glutamic acid. If desired, the compounds of formula (IV) can be converted into their acidic or basic salts by reaction with inorganic acids, such as hydrochloric acid, hydrobromic acid, sulphuric acid, nitric acid, perchloric acid or with inorganic bases such as alkaline or alkaline-earth metal hydroxides and ammonium hydroxide.
  • The compounds of formula (IV) and (V) are disclosed as another aspect of the present invention.
  • A particularly preferred embodiment is a compound of formula (IV) wherein R1CO is a D- or L-pyroglutamic acid residue and the content of the N-terminus free amine is lower than 1% w/w, preferably lower than 0.2% w/w.
  • The process described above for the preparation of a compound of formula (IV) has general applicability, that is to say that, further to a carboxylic acid R1COOH, or an activated carboxylic acid, such as an acyl chloride R1COCl or an anhydride (RICO)2O, any compound able to react with the —NH2 terminus can be used for the reaction with the compound of formula (III). Examples of such compounds are aldehydes, ketones, α,β-unsaturated ketones, sulfonyl chlorides and nitriles, which can be reacted with compound (III) according to methods known to the skilled chemist. According to a further embodiment of the invention either the carboxylic acid, or activated carboxylic acid, or anhydride, or compound able to react with the —NH2 terminus may also bear at least a group, such as a hydroxy, an amino or a thio group, which can be further functionalized with a moiety suitable for modulating the pharmacokinetic properties of poly-α-glutamic acid. Therefore, another aspect of the present invention is also a poly-α-glutamic acid substituted at the —NH2 terminus with a group which is able to be further functionalized with a moiety suitable for modulating the pharmacokinetic properties of poly-α-glutamic acid.
  • Embodiments of the invention will be hereinafter illustrated in greater detail in the following examples. The examples are offered by way of illustration and not by way of limitation.
  • EXAMPLES Example 1 Step a Preparation of L-α-Glu-NCA-γ-tBu ester
  • Figure US20080051603A1-20080228-C00017
  • 40.17 g of triphosgene (0.135 mol; phosgene/L-Glu-γ-tBu ester 2.74/1) and 862.5 mL of THF were placed under nitrogen into a 1 L jacketed reactor, equipped with mechanical stirrer. The reactor was thermostated at 20° C. and the mixture was stirred until complete dissolution of triphosgene (a few minutes are necessary), thereafter 30 g of L-α-Glu-γ-tBu ester (0.148 mol) were added in a single portion and quite rapidly. The resulting suspension was allowed to react for 2 hours at 20° C. At the beginning exothermicity was observed (≈4° C.), then the solid dissolved as the reaction proceeded: after about 30 min a clear solution was obtained.
  • At the end of the reaction the solvent was evaporated under reduced pressure, keeping the jacket temperature not higher than 20° C.: the distillation was quite tumultuous. The distillation was continued until a dense and oily residue was obtained, without solids (about 80 mL of residue expected). At the end of the distillation 750 mL of n-heptane were dropped in over about 15 min and the mixture was stirred under nitrogen at 20/23° C. for 1 hour until complete crystallization of the product. Usually, crystallization begins after addition of 150 mL of n-heptane.
  • The resulting pure white solid was filtered on a buchner funnel and washed with 3×90 mL of n-heptane, then dried in the oven under dynamic vacuum at 20/25° C. for no longer than 20 hours. The solid must be used as soon as possible and must be stored under static vacuum in the presence of silica gel.
  • Starting from 30 g of L-α-Glu-γ-tBu ester, 23.3 g of L-α-Glu-NCA-γ-tBu ester were obtained (68.8% yield).
  • Step b Polymerization of α-L-glutamic acid-γ-(tert-butyl)ester N-carboxy anhydride) (NCA) to poly-α-L-glutamic acid-γ-(tert-butyl)ester
  • Figure US20080051603A1-20080228-C00018
  • 1,8-Diazabiciclo[5.4.0]undec-7-ene free base (DBU; MW 152.24; 585 mg, 3.84 mmol) was dissolved in 1,4-dioxane (5 mL from the total amount) in few minutes.
  • In a 1 L jacketed glass reactor 1,4-dioxane (550 mL) and α-L-glutamic acid-γ-(tert-butyl)ester N-carboxy anhydride (NCA) (22 g, 96 mmol; NCA/DBU=25) were mixed at 25° C. until dissolution was complete.
  • The resulting solution was added very quickly with the previously prepared DBU solution. A precipitate instantly appeared and low exothermicity was observed (about 3° C.).
  • The mixture was stirred for 4 hours, then water (1100 mL) was slowly poured in over 30 to 40 minutes. After a further 30 minutes stirring at 25° C. the precipitated solid was collected by filtration and washed with water (3×50 mL). The recovered white solid was then dried under vacuum at 40° C. to yield 16.4 g of pure material, t-BuPG (92% recovery; DPn=137.2, number average degree of polymerization; Mn=25,400 Da, number average molecular weight from 1H-NMR).
  • Step c Hydrolysis of poly-α-L-glutamic acid-γ-(tert-butyl)ester to poly-α-L-glutamic acid
  • Figure US20080051603A1-20080228-C00019
  • Solid poly-α-L-glutamic acid-γ-(tert-butyl)ester (4 g) was suspended in formic acid 99% (80 mL, 20 volumes) under nitrogen atmosphere in a 100 mL jacketed glass reactor. The mixture was stirred at 60° C. for 5 hours. After about a 30-minute heating the suspension turned into solution, then a solid began to precipitate.
  • Most of the formic acid was then removed by distillation under reduced pressure (P=15 torr; internal temperature always below 60° C.). The residual formic acid was evaporated off by azeotropic distillation with toluene (2×40 mL; T<40° C.).
  • The resulting residue was suspended in water (40 mL) and the mixture was cooled to 3-5° C., then 30% w/w NaOH was carefully added to reach pH 8. Once the pH was stable at 23-25° C., the resulting solution was filtered through a 0.22 μm microfilter.
  • The clear solution was acidified by means of sulphuric acid up to pH 2.5, then the resulting suspension was stirred for 2 hours. The precipitated solid was filtered off and dried under vacuum (30° C. overnight). A white cake was recovered (2.7 g) with a Mw=13,900 Da and polydispersity 1.04 (GPC-MALLS).
  • Example 2
  • α-L-glutamic acid-γ-(tert-butyl)ester N-carboxy anhydride (3.95 g, 17.2 mmol) was dissolved, under nitrogen stream, in THF (100 mL) to reach a concentration of 0.039 g/mL (0.17 M). The stirring speed was set to 800 rpm.
  • Then DBU (105 mg, A/I=25) was added by a syringe very quickly and the mixture was stirred for 4 hours at 22-23° C. A slight exotherm was observed soon after addition of the initiator.
  • Afterwards, the reaction mixture was concentrated to dryness and the residue was rinsed with fresh 1,4-dioxane (100 mL). Two volumes of water were then added to the reaction mixture which was stirred for 30 minutes. The precipitated solid was collected, washed with water and dried under vacuum at 40° C. for at least 12 hours.
  • 2.85 g of poly-α-L-glutamic acid-γ-(tert-butyl)ester (90% recovery) as a white powder with Mn=34,100 Da and DPn=184 (by 1H-NMR) were obtained.
  • The resulting poly-α-L-glutamic acid-γ-(tert-butyl)ester was then hydrolyzed in hot 99% HCOOH according to the procedure described in step c of Example 1, furnishing about 1.7 g of poly-α-L-glutamic acid (84% recovery) with Mw=25,700 and polydispersity=1.2 according to Gel Permeation Chromathography coupled with Multi Angle Laser Light Scattering analysis.
  • Example 3 General Procedure for the Polymer Capping Reaction
  • A typical poly-α-L-glutamic acid-γ-(tert-butyl)ester, obtained according to an experimental procedure herein described (see Example 1 and 2), contains about 1% moles of free amino groups at the N-terminus, as determined by 1H-NMR analysis. This percentage was used to calculate the molar equivalents of the suitable acid to add to poly-α-L-glutamic acid-γ-(tert-butyl)ester for its capping reaction.
  • Poly-α-L-glutamic acid-γ-(tert-butyl)ester was dissolved in THF (20 mL/g) then a catalytic amount of 4-dimethylaminopyridine (DMAP; about 5-10% moles with respect to the added acid) was added. The suitable acid (10 molar equivalents) was added to the previous mixture and diisopropylcarbodiimide (DIPC, 50% molar excess with respect to the acid added) was dropwise added in about 10 min. The solution was stirred for 2 hours.
  • Two volumes of water were then added and the resulting mixture was stirred for 30 min. The precipitated solid consisting of N-acyl-poly-α-L-glutamic acid-γ-(tert-butyl)ester was collected and then suspended in formic acid (20 volumes). After stirring at 60° C. for 2 h, two volumes of water were added and the resulting mixture was stirred for 30 min. The precipitated solid was removed by filtration, washed with water and dried under vacuum (30° C., overnight) to yield a suitably N-capped poly-α-L-glutamic acid (N-acyl-poly-L-α-glutamic acid).
  • Example 3A
  • Poly-α-L-glutamic acid-γ-(tert-butyl)ester (1 g, 5.37 mmol) was dissolved in THF (20 mL) and catalytic DMAP (8 mg, 0.07 mol) was added. Then N—BOC-L-Phenylalanine (180 mg, 0.7 mol) was added to the mixture and immediately after DIPC (160 μL, 1 mmol) was dropwise added. The resulting solution was stirred for about two hours then water (2 volumes) was added and a white precipitate formed immediately. The suspension was stirred for 30 min and filtered, then the white powdered solid was suspended in formic acid (18 mL). The resulting mixture was stirred for 2 h at 60° C. and formic acid was removed by distillation at reduced pressure (P=15 torr) followed by azeotropic distillation with toluene (2×10 mL of toluene) under slight vacuum (Lakhanpal M. L.; Mandal H. G.; Lal G.; Indian J. Chem, 13, 1309 (1975)). The solid residue was dissolved in aqueous NaHCO3 and the resulting solution was ultrafiltered through a 5,000 Da cutoff membrane. The retentate was concentrated to about 30 mL and acidified with sulphuric acid until pH 2-2.5. The precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-terminus phenylalanine-capped poly-α-L-glutamic acid, i.e., N-phenylalanyl-poly-α-L-glutamic acid (530 mg, 84% recovery). The 1H-NMR was consistent with the proposed structure.
  • The N-terminal free amine content (clearly detectable at the poly-α-L-glutamic acid-γ-(tert-butyl)ester stage) was no longer detectable by 1H-NMR analysis or by analysis following derivatization with o-phthalaldehyde.
  • Mw=13,300 polydispersity=1.16 as determined by GPC-MALLS analysis.
  • Example 3B
  • Poly-α-L-glutamic acid-γ-(tert-butyl)ester (1 g, 5.37 mmol) was dissolved in THF (40 mL) and DMAP (42 mg, 0.34 mol) was added. Then L-pyroglutamic acid (44 mg, 0.34 mol) was added to the mixture and immediately after DIPC (106 μL, 0.7 mmol) was dropwise added. The resulting solution was stirred for about two hours then water (2 volumes) was added and a white precipitated formed immediately. The suspension was stirred for 30 min, then filtered and the recovered white powder was suspended in formic acid (18 mL). The resulting mixture was stirred for 2 h at 60° C. and formic acid was removed by distillation at reduced pressure (P=15 torr) followed by azeotropic distillation with toluene (2×10 mL of toluene) under slight vacuum. The solid residue was dissolved in aqueous NaHCO3 and the resulting solution was ultrafiltered through a 5,000 Da cutoff membrane. The retentate was concentrated to about 30 mL and acidified by means of sulphuric acid until pH 2-2.5. The precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-terminus pyro-L-glutamic-capped poly-α-L-glutamic acid (400 mg, 64% recovery). The 1H-NMR was consistent with the proposed structure and the free amine (clearly detectable at the poly-α-L-glutamic acid-γ-(tert-butyl)ester stage) was no longer detectable by 1H-NMR or o-phthalaldehyde analysis.
  • Example 3C
  • Naphthalen-2-yl-acetic acid (19.7 mg, 0.106 mmol) and N-methyl morpholine (23.7 mg, 25.7 μL, 0.234 mmol) were dissolved in CH2Cl2 (10 mL) and the mixture was cooled at 0° C.
  • Chlorotripyrrolidinophosphonium hexafluorophosphate (PyClop, 0.106 mmol, 44.7 mg) was added to the mixture and the resulting solution was stirred for about 1 hour, then poly-α-L-glutamic acid-γ-(tert-butyl)ester was added quickly (n≈100; 1 g, 0.054 mmol) and the reaction was stirred for additional 5 hours after the removal of the cooling bath. The solvent was evaporated under reduced pressure. The crude material was dissolved again in THF (10 mL) and water (2 volumes) was added. The resulting suspension was stirred for 30 min, then it was filtered and the recovered white powder was suspended in formic acid (18 mL). The resulting mixture was stirred for 2 h at 60° C. The mixture was cooled down and formic acid was removed by distillation at reduced pressure (P=15 torr) followed by azeotropic distillation with toluene (2×10 mL each). The solid residue was dissolved in aqueous NaHCO3 and the resulting solution was ultrafiltered through a 5000 Da cutoff membrane. The retentate was concentrated to about 30 mL and acidified by means of sulfuric acid until pH 2-2.5. The precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-(Naphthalen-2-yl-acetyl)-poly-α-L-glutamic acid (570 mg, 82% recovery). The 1H-NMR was consistent with the proposed structure and the free amine (clearly detectable at the poly-α-L-glutamic acid-γ-(tert-butyl)ester stage) was no longer detectable by 1H-NMR or o-phthalaldehyde analysis.
  • Example 3D
  • Naphthalen-2-yl-acetic acid (31.7 mg, 0.17 mmol), TEA (3.5 mg, 4.7 μL, 0.034 mmol) and N,N′-disuccinimidyl carbonate (DSC, 43.6 mg 0.17 mmol), were dissolved in a 1:1 mixture of CH2Cl2/CH3CN (2 mL) and the resulting mixture was stirred at room temperature for 2 hours. The mixture was dropwise added to a poly-α-L-glutamic acid-γ-(tert-butyl)ester (n≈100; 1 g, 0.054 mmol) solution in CH2Cl2 (10 mL) and the resulting solution was stirred overnight. The solvent was then removed under reduced pressure and the crude material was processed in the same way as described in the Example 3C.
  • The recovered solid, after drying under vacuum (30° C., overnight), furnished the corresponding N-(Naphthalen-2-yl-acetyl)-poly-α-L-glutamic acid (612 mg, 88% recovery). The 1H-NMR was consistent with the proposed structure and the free amine (clearly detectable at the poly-α-L-glutamic acid-γ-(tert-butyl)ester stage) was no longer detectable by 1H-NMR or o-phthalaldehyde analysis.
  • Example 3E
  • Poly-α-L-glutamic acid-γ-(tert-butyl)ester (n≈100; 1 g, 0.054 mmol) was dissolved in THF (20 mL) and catalytic DMAP (8 mg, 0.07 mmol) was added. Then 2-thiophenebutyric acid (119 mg, 0.7 mmol) was added to the mixture and immediately after DIPC (160 μL, 1 mmol) was dropwise added. The resulting solution was stirred for about two hours then water (2 volumes) was added and a white precipitate formed immediately. The suspension was stirred for 30 min and filtered, then the white powdered solid was suspended in formic acid (18 mL). The resulting mixture was stirred for 2 h at 60° C. and formic acid was removed by distillation at reduced pressure (P=15 torr) followed by azeotropic distillation with toluene (2×10 mL of toluene) under slight vacuum. The solid residue was dissolved in aqueous NaHCO3 and the resulting solution was filtered on a fiberglass filter (0.2 μm). The filtrate was acidified with H2SO4 2N until pH 2-2.5. The precipitated material was stirred for 30 min and recovered by filtration yielding, after drying under vacuum (30° C., overnight), the corresponding N-terminus 2-thiophenebutyroyl-capped poly-α-L-glutamic acid, i.e., N-(2-thiophenebutyroyl)-poly-α-L-glutamic acid (480 mg, 76% recovery). The 1H-NMR was consistent with the proposed structure.
  • The N-terminal free amine content (clearly detectable at the poly-α-L-glutamic acid-γ-(tert-butyl)ester stage) was no longer detectable by 1H-NMR analysis or by analysis following derivatisation with o-phthalaldehyde.
  • Mw=13,300, polydispersity=1.12 as determined by GPC-MALLS analysis.
  • According to a very similar procedure, N-(2-thiophenepropanoyl)-poly-α-L-glutamic acid and N-(2-thiophenepentanoyl)-poly-α-L-glutamic acid, were also obtained.
  • All of the above U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet, are incorporated herein by reference, in their entirety.
  • From the foregoing it will be appreciated that, although specific embodiments of the invention have been described herein for purposes of illustration, various modifications may be made without deviating from the spirit and scope of the invention.

Claims (34)

1. A process for the preparation of poly-α-glutamic acid of formula (I)
Figure US20080051603A1-20080228-C00020
wherein the symbol * indicates a chiral center and n is between 60 and 310, so that the poly-α-glutamic acid has a molecular weight ranging from 8,000 to 40,000 Da
said process comprising the steps of:
polymerization of a tertiary γ-ester of α-glutamic acid N-carboxy anhydride of formula (II)
Figure US20080051603A1-20080228-C00021
wherein the symbol * is a defined above and R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl
in water or in an organic solvent selected from: tetrahydrofuran, 1,4-dioxane, dimethylformamide, 1,4-dioxane/DMF and 1,4-dioxane/tetrahydrofuran mixture with an initiator selected from potassium tert-butoxide, sodium methoxide, diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene, dimethylaminopyridine and L-glutamic acid-γ-tert-butylester, to give a compound of formula (III)
Figure US20080051603A1-20080228-C00022
wherein * and R are as defined above and R′ is hydrogen when the initiator is selected from diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene, 4-dimethylaminopyridine, glutamic acid dimethyl ester and glutamic acid-γ-tert-butyl ester or R′ is a t-butyl or methyl group when the initiator is potassium tert-butoxide and sodium methoxide respectively; and followed by
b) acid hydrolysis of the γ- and α-ester groups to give a compound of formula (I).
2. The process according to claim 1 wherein the solvent is 1,4-dioxane and the initiator is 1,8-diazabicyclo[5,4,0]undec-7-ene.
3. The process according to claim 1 wherein the temperature ranges from 10 to 50° C.
4. The process according to claim 2 wherein the temperature ranges from 10 to 50° V.
5. The process according to claim 1 wherein the concentration of the tertiary γ-ester of α-glutamic acid N-carboxy anhydride ranges from 0.1 to 0.3 M.
6. The process according to claim 2 wherein the concentration of the tertiary γ-ester of α-glutamic acid N-carboxy anhydride ranges from 0.1 to 0.3 M.
7. The process according to claim 3 wherein the concentration of the tertiary γ-ester of α-glutamic acid N-carboxy anhydride ranges from 0.1 to 0.3 M.
8. The process according to claim 4 wherein the concentration of the tertiary γ-ester of α-glutamic acid N-carboxy anhydride ranges from 0.1 to 0.3 M.
9. The process according to claim 1 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
10. The process according to claim 2 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
11. The process according to claim 3 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
12. The process according to claim 4 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
13. The process according to claim 5 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
14. The process according to claim 6 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
15. The process according to claim 7 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
16. The process according to claim 8 wherein step b) is carried out in an acid selected from trifluoroacetic acid, formic acid and water/formic acid mixtures at a temperature ranging from 20 to 60° C.
17. The process according to claim 1 wherein R is t-butyl.
18. The process according to any one of claims 1 to 17 wherein the molecular weight of the poly-α-glutamic acid (I) ranges from 13,000 to 16,000 Da and the polydispersity index is ≦1.5.
19. A process for the preparation of a poly-α-glutamic acid derivative of formula (IV)
Figure US20080051603A1-20080228-C00023
wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310 and R1CO— is selected from:
(C1-C10)alkylcarbonyl;
(C4-C8)cycloalkylcarbonyl;
(C2-C6)carboxyalkylcarbonyl;
(C6-C10)arylcarbonyl;
(C6-C10)aryl(C1-C10)alkylcarbonyl;
(C1-C10)alkyl(C6-C10)arylcarbonyl;
(C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; and
D- or L-amino acid and non-natural amino acid residues;
said process comprising the steps of:
a) polymerization of a tertiary γ-ester of an α-glutamic acid N-carboxy anhydride of formula (II)
Figure US20080051603A1-20080228-C00024
wherein * is as defined above and R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl
in water or in an organic solvent selected from: tetrahydrofuran, 1,4-dioxane, dimethylformamide, 1,4-dioxane/DMF and 1,4-dioxane/tetrahydrofuran mixtures with an initiator selected from potassium tert-butoxide, sodium methoxide, diisopropylethylamine, 1,8-diazabicyclo[5,4,0]undec-7-ene, dimethylaminopyridine and L-glutamic acid-γ-tert-butylester, to give a compound of formula (III);
b) reaction of a compound of formula (III)
Figure US20080051603A1-20080228-C00025
obtained according to step a) above with a carboxylic acid R1COOH, or an acyl chloride R1COCl or an anhydride (R1CO)2O wherein R1 is as defined above, in the presence of a dehydrating agent to give a compound of formula (V)
Figure US20080051603A1-20080228-C00026
and
c) the hydrolysis of the compound of formula (V) to give a compound of formula (IV).
20. The process according to claim 19 wherein (C1-C10)alkylcarbonyl is acetyl or butyryl.
21. The process according to claim 19 wherein (C4-C8)cycloalkylcarbonyl is cyclopropylcarbonyl, cyclobutanecarbonyl, or cyclohexylcarbonyl.
22. The process according to claim 19 wherein (C2-C6)carboxyalkylcarbonyl is succinyl.
23. The process according to claim 19 wherein (C6-C10)arylcarbonyl is benzoyl, 1-naphthoyl or 2-naphthoyl.
24. The process according to claim 19 wherein (C6-C10)aryl(C1-C10)alkylcarbonyl is phenylacetyl or phenylbutyryl.
25. The process according to claim 19 wherein (C1-C10)alkyl(C6-C10)aryl carbonyl is o-, m- or p-tolyl.
26. The process according to claim 19 wherein (C5-C10)heteroarylcarbonyl is nicotinoyl, N-methylpyrrole-3-carbonyl, 3-thiophenecarbonyl or 3-quinolinecarbonyl.
27. The process according to claim 19 wherein (C5-C10)heteroaryl(C1-C10)alkylcarbonyl is 3-pyridylacetyl.
28. The process according to claim 19 wherein D- or L-natural amino acid residues are those deriving from glycine, alanine, valine, leucine, isoleucine, serine, threonine, lysine, pyroglutamic acid, phenylalanine, tryptophan and cysteine.
29. The process according to claim 28 wherein the amino acid residue is a phenylalanine residue.
30. The process according to claim 19 wherein D or L non-natural amino acid residues are those deriving from β-alanine, α,α-dimethylglycine, α-phenylglycine, homophenylalanine, 3-amino-3-(4-methylphenyl)propionic acid, and 2-(1-aminocyclopentyl)acetic acid.
31. A poly-α-glutamic acid derivative of formula (IV)
Figure US20080051603A1-20080228-C00027
wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310 and R1CO— is selected from:
(C1-C10)alkylcarbonyl;
(C4-C8)cycloalkylcarbonyl;
(C6-C10)arylcarbonyl;
(C6-C10)aryl(C1-C10)alkylcarbonyl;
(C1-C10)alkyl(C6-C10)arylcarbonyl;
(C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; and
D- or L-amino acid and non-natural amino acid residues as well as their salts with inorganic acids or bases.
32. The compound according to claim 31 wherein R1CO is a D- or L-pyroglutamic acid residue and the content of the N-terminus free amine is lower than 1% w/w, preferably lower than 0.2% w/w.
33. A poly-α-glutamic acid derivative of formula (V)
Figure US20080051603A1-20080228-C00028
wherein the symbol * indicates a chiral center and n is an integer comprised between 60 and 310, R is selected from t-butyl, 1,1-dimethylpropyl and 1,1-dimethylbutyl, R′ is hydrogen or a t-butyl or methyl group and R1CO is selected from:
(C1-C10)alkylcarbonyl;
(C4-C8)cycloalkylcarbonyl;
(C6-C10)arylcarbonyl;
(C6-C10)aryl(C1-C10)alkylcarbonyl;
(C1-C10)alkyl(C6-C10)arylcarbonyl;
(C5-C10)heteroarylcarbonyl and (C5-C10)heteroaryl(C1-C10)alkylcarbonyl wherein the heteroaromatic ring contains one or more nitrogen, oxygen or sulphur atoms; and
D- or L-amino acid and non-natural amino acid residues.
34. The poly-α-glutamic acid derivative according to claim 31 or claim 33 substituted at the —NH2 terminus with a group which is able to be further functionalized with a moiety suitable for modulating the pharmacokinetic properties of poly-α-glutamic acid.
US11/818,056 2006-06-15 2007-06-12 Process for the preparation of poly-alpha-glutamic acid and derivatives thereof Abandoned US20080051603A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/818,056 US20080051603A1 (en) 2006-06-15 2007-06-12 Process for the preparation of poly-alpha-glutamic acid and derivatives thereof
US12/965,510 US8329853B2 (en) 2006-06-15 2010-12-10 Process for the preparation of poly-α-glutamic acid and derivatives thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81378706P 2006-06-15 2006-06-15
EP06012351A EP1867657A1 (en) 2006-06-15 2006-06-15 Process for the preparation of poly-a-glutamic acid and derivatives thereof
EP06012351.0 2006-06-15
US11/818,056 US20080051603A1 (en) 2006-06-15 2007-06-12 Process for the preparation of poly-alpha-glutamic acid and derivatives thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/965,510 Continuation US8329853B2 (en) 2006-06-15 2010-12-10 Process for the preparation of poly-α-glutamic acid and derivatives thereof

Publications (1)

Publication Number Publication Date
US20080051603A1 true US20080051603A1 (en) 2008-02-28

Family

ID=39197547

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/818,056 Abandoned US20080051603A1 (en) 2006-06-15 2007-06-12 Process for the preparation of poly-alpha-glutamic acid and derivatives thereof
US12/965,510 Expired - Fee Related US8329853B2 (en) 2006-06-15 2010-12-10 Process for the preparation of poly-α-glutamic acid and derivatives thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/965,510 Expired - Fee Related US8329853B2 (en) 2006-06-15 2010-12-10 Process for the preparation of poly-α-glutamic acid and derivatives thereof

Country Status (1)

Country Link
US (2) US20080051603A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
US20080253969A1 (en) * 2007-04-10 2008-10-16 Nitto Denko Corporation Multi-functional polyglutamate drug carriers
US20080279782A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polymers conjugated with platinum drugs
US20090226393A1 (en) * 2008-03-06 2009-09-10 Nitto Denko Corporation Polymer paclitaxel conjugates and methods for treating cancer
US20100093935A1 (en) * 2008-10-15 2010-04-15 Nitto Denko Corporation Method of preparing polyglutamate conjugates
US20110144315A1 (en) * 2009-12-16 2011-06-16 Nitto Denko Corporation Controlled synthesis of polyglutamic acid
US8197828B2 (en) 2007-05-09 2012-06-12 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
US9855338B2 (en) 2005-12-05 2018-01-02 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175898A1 (en) * 2013-04-26 2014-10-30 Nitto Denko Corporation A large scale process for preparing poly (glutamyl-glutamate) conjugates

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2629716A (en) * 1948-07-07 1953-02-24 Du Pont Preparation and hydrolysis of esters
US3635909A (en) * 1969-06-18 1972-01-18 Kyowa Hakko Kogyo Kk Method for polymerizing alpha-amino acid n - carboxyanhydrides using alkali metal salts of 2-pyrrolidone
US4666886A (en) * 1983-01-25 1987-05-19 Ciba-Geigy Corporation Novel peptide derivatives
US6590061B1 (en) * 1998-06-05 2003-07-08 Institute Of Macromolecular Chemistry Of The Academy Of Sciences Of The Czech Republic Functionalized polymers of α-amino acids and the method of preparation thereof
US7317070B1 (en) * 2004-03-12 2008-01-08 Sigma-Aldrich Co. Process for the preparation of polyamino acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112673B2 (en) * 1971-09-06 1976-04-21
NZ332234A (en) 1996-03-12 2000-06-23 Pg Txl Company Lp Water soluble paclitaxel prodrugs formed by conjugating paclitaxel or docetaxel with a polyglutamic acid polymer and use for treating cancer
CA2656077C (en) 2006-06-15 2014-12-09 Marc Mckennon A process for the preparation of poly-alpha-glutamic acid and derivatives thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2629716A (en) * 1948-07-07 1953-02-24 Du Pont Preparation and hydrolysis of esters
US3635909A (en) * 1969-06-18 1972-01-18 Kyowa Hakko Kogyo Kk Method for polymerizing alpha-amino acid n - carboxyanhydrides using alkali metal salts of 2-pyrrolidone
US4666886A (en) * 1983-01-25 1987-05-19 Ciba-Geigy Corporation Novel peptide derivatives
US6590061B1 (en) * 1998-06-05 2003-07-08 Institute Of Macromolecular Chemistry Of The Academy Of Sciences Of The Czech Republic Functionalized polymers of α-amino acids and the method of preparation thereof
US7317070B1 (en) * 2004-03-12 2008-01-08 Sigma-Aldrich Co. Process for the preparation of polyamino acids

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9855338B2 (en) 2005-12-05 2018-01-02 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
US20080253969A1 (en) * 2007-04-10 2008-10-16 Nitto Denko Corporation Multi-functional polyglutamate drug carriers
US20080279782A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polymers conjugated with platinum drugs
US8197828B2 (en) 2007-05-09 2012-06-12 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
US8329199B2 (en) 2007-05-09 2012-12-11 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
US20090226393A1 (en) * 2008-03-06 2009-09-10 Nitto Denko Corporation Polymer paclitaxel conjugates and methods for treating cancer
US20100093935A1 (en) * 2008-10-15 2010-04-15 Nitto Denko Corporation Method of preparing polyglutamate conjugates
US20110144315A1 (en) * 2009-12-16 2011-06-16 Nitto Denko Corporation Controlled synthesis of polyglutamic acid
EP2513133A1 (en) * 2009-12-16 2012-10-24 Nitto Denko Corporation Controlled synthesis of polyglutamic acid
EP2513133A4 (en) * 2009-12-16 2014-07-02 Nitto Denko Corp Controlled synthesis of polyglutamic acid

Also Published As

Publication number Publication date
US20110196123A1 (en) 2011-08-11
US8329853B2 (en) 2012-12-11

Similar Documents

Publication Publication Date Title
US8329853B2 (en) Process for the preparation of poly-α-glutamic acid and derivatives thereof
US7317070B1 (en) Process for the preparation of polyamino acids
US8212002B2 (en) Synthesis of glatiramer acetate
US9988492B2 (en) Methods for post-fabrication functionalization of poly(ester ureas)
WO2019198834A1 (en) Method for producing leuprorelin
HU228392B1 (en) Process for producing n-carboxi-anhidrides
CA2656077C (en) A process for the preparation of poly-alpha-glutamic acid and derivatives thereof
US20060263328A1 (en) Hydrophilic polymers with pendant functional groups and method thereof
EP1088020A1 (en) Functionalised polymers of alpha-amino acids and the method of preparation thereof
EP2364991A1 (en) A process for the preparation of poly-alfa-glutamic acid and derivatives thereof
WO2009058291A2 (en) Controlled molecular weight amino acid polymers having functionalizable backbones and end groups and processes for preparing the same
US6828392B2 (en) Hydroxy and amine functionalized resins
JP3413898B2 (en) Polymer compound and method for producing the same
KR102393533B1 (en) Methods for purifying amino acid n-carboxyanhydride
EP2406300B1 (en) Method for the production of polyamino acid random copolymers
JP3418693B2 (en) D-galactopyranosyl-gluconic acid derivatives of poly-ε-substituted-L-lysine
JPH0543560A (en) New n-carboxyamino acid anhydride and production of polypeptide using the same as raw material
JPH08169953A (en) Polyamino acid derivative and its production
JPH04316571A (en) Production of n-protected aspartic acid anhydride

Legal Events

Date Code Title Description
AS Assignment

Owner name: CELL THERAPEUTICS EUROPE S.R.L., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DA RE, GIOVANNI;FELICIOTTI, LUCA;ARTICO, MARCO;AND OTHERS;REEL/FRAME:020059/0161;SIGNING DATES FROM 20071024 TO 20071029

Owner name: CELL THERAPEUTICS, INC., WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MCKENNON, MARC;REEL/FRAME:020059/0153

Effective date: 20070912

AS Assignment

Owner name: CELL THERAPEUTICS, INC., WASHINGTON

Free format text: MERGER;ASSIGNOR:CELL THERAPEUTICS EUROPE S.R.L.;REEL/FRAME:020252/0158

Effective date: 20071113

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION